Skip to content
Buy This GLP
← Research
Safety

Do You Have to Stop a GLP-1 Before Surgery or an Endoscopy?

One endoscopy study found retained stomach contents in 5.83% of people who continued a GLP-1 and 0.4% of non-users. Ask your procedure team how to manage your medication.

Editorial profile: Carla MedinaBuy This GLP Editorial Team9 min read
Food still in the stomach at endoscopyno GLP-1 use63 / 15,9020.4%kept taking it6 / 1035.83%OR 10.68held two weeks1 / 621.61%one caseThe reassuring bar is a single patient.

The trials of GLP-1 use around heart surgery asked about blood sugar during that procedure. Before an upper endoscopy, a separate concern is whether food remains in the stomach. One study found retained contents in 5.83% of people who continued a GLP-1 until endoscopy and 0.4% of non-users, an odds ratio of 10.68 (95% CI 3.74–30.55) [1]. Ask the team performing your procedure how to handle the medication.

A retrospective study at one center compared people who continued a GLP-1, people who held it for two weeks, and non-users having elective upper endoscopy. A separate ultrasound study of fasting adolescents looked at retained stomach contents in a younger population. The two studies examined different settings and cannot establish one fasting plan for both.

What the endoscopy study found

The study defined retained stomach contents as solid residue or more than 100 mL of fluid. It found retained contents in six of 103 people who continued taking a GLP-1 (5.83%) and 63 of 15,902 non-users (0.4%)[1]. This observational comparison measured stomach contents at endoscopy.

The two-week hold group came in at 1.61%, which the authors describe as statistically comparable to not using the drug at all. That is where care is needed.

What ultrasound found after fasting

Fasting instructions before surgery assume the stomach empties, and a prospective cohort scanned 67 adolescents with gastric ultrasound to check [2]. Twenty of them were on a GLP-1, and solids were still present in 16 of those 20 after a median fast of 13 hours. Healthy controls came in at 1 of 20.

The study also found solids in 17 of 27 adolescents in a separate at-risk group. These ultrasound findings describe that cohort. They do not show how a longer fast would change outcomes.

How long a hold, and before what

A retrospective study of 80 lipoabdominoplasty patients reported 30-day complication rates of 45% with continued semaglutide, 30% after a two-week hold, 10% after a four-week hold, and 10% among patients who had never used it[3]. The review of semaglutide before body contouring explains the group comparisons. This study cannot set a hold duration for other operations.

A review of four randomized cardiac-surgery trials included 446 participants[4]. The estimates for mortality, complications and hypoglycemia were uncertain. For postoperative nausea and vomiting, the risk ratio was 3.01, with a 95% confidence interval of 0.26 to 35.27. These trials tested perioperative liraglutide and did not compare medication hold durations.

What else the endoscopy study examined

The researchers explored whether body mass index and having a colonoscopy at the same visit were associated with retained contents[1]. Those findings came from a retrospective study and do not establish which preparation will work for an individual.

Our review of blood clots after hip replacement looks at a separate outcome after surgery. The two studies answer different questions about perioperative care.

What to do with all of this

Multisociety guidance recommends deciding with the prescriber, procedure team and anesthesia team. It allows continuation for patients at low risk of delayed stomach emptying and calls for an individualized plan when risk is higher[5].

Ask the team performing the procedure how to handle your medication. Tell them the drug, your current dose and when you last took it. The guide to missed Ozempic doses explains the routine label instructions. Your procedure team can give instructions specific to your appointment.

Once your care team gives you a plan, use the guide to prepaid treatment terms to see what to ask about billing. Check with the provider whether a pause changes the next shipment or payment date.

Frequently asked

Do you have to stop a GLP-1 before surgery?
Ask your prescriber and procedure team. Multisociety guidance allows continuation for patients at low risk of delayed stomach emptying and recommends an individualized plan when risk is higher.
Is two weeks long enough?
The two-week hold group recorded 1.61%, described as statistically comparable to no use. That rests on a single case in 62 patients, with a confidence interval from 0.37 to 23.89, so the study found no difference rather than showing there is none.
Does a longer fast fix it?
The cohort found solids in 16 of 20 adolescents using a GLP-1 after a median 13-hour fast and in 1 of 20 controls. It did not compare different fasting durations.
What about cosmetic surgery after weight loss?
In an abdominoplasty series, 30-day complications ran 45% with semaglutide continued to surgery, 30% at two weeks and 10% at four weeks, matching the 10% in patients who had never taken it. Each group held 20 patients.
Does body weight change the answer?
The study examined BMI as a factor in retained stomach contents. Ask the procedure team how your medical history affects your preparation.

Sources

  1. [1] Dong Z, Li O, Wu J, Li Y, et al. (2026). Effect of two-week perioperative glucagon-like peptide-1 receptor agonist interruption on retained gastric contents during esophagogastroduodenoscopy: a retrospective, observational study Surgical Endoscopy. PMID 42426387
  2. [2] O'Brien EM, et al. (2026). Delayed gastric emptying in adolescent patients on GLP-1 receptor agonists with standard preoperative fasting guidelines: a prospective cohort study British Journal of Anaesthesia. PMID 42711215
  3. [3] Bruno A, Calicchia A, Schirosi M (2026). Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study Aesthetic Plastic Surgery. PMID 42286330
  4. [4] Gamal I, et al. (2026). Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Cardiology in Review. PMID 42693519
  5. [5] American Gastroenterological Association and partner societies (2024). Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period Clinical Gastroenterology and Hepatology. Source

More in Safety